A single nucleotide polymorphism (SNP) in the FPR2 promoter (A > G 220), associated with reduced FPR2 gene (10‐fold) and protein (3‐fold) expression, was identified from genotyping polymorphonuclear leukocytes from 232 subjects, detected in 1 of 132 patients under 55 years old with prior myocardial infarction, but not in 100 healthy individuals (Simiele et al., 2012). This evidence concerns the gene FPR2 and myocardial infarction.